Cargando…
New advances in amblyopia therapy I: binocular therapies and pharmacologic augmentation
Amblyopia therapy options have traditionally been limited to penalisation of the non-amblyopic eye with either patching or pharmaceutical penalisation. Solid evidence, mostly from the Pediatric Eye Disease Investigator Group, has validated both number of hours a day of patching and days per week of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241622/ https://www.ncbi.nlm.nih.gov/pubmed/29777043 http://dx.doi.org/10.1136/bjophthalmol-2018-312172 |